This document is an excerpt from the EUR-Lex website
Document 52005XC1028(11)
European Medicines Agency — Publication of the final accounts for the financial year 2004
European Medicines Agency — Publication of the final accounts for the financial year 2004
European Medicines Agency — Publication of the final accounts for the financial year 2004
IO C 269, 28.10.2005, p. 17–20
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, SK, SL, FI, SV)
28.10.2005 |
EN |
Official Journal of the European Union |
C 269/17 |
European Medicines Agency — Publication of the final accounts for the financial year 2004
(2005/C 269/05)
The complete version of the final accounts may be found at the following address:
www.emea.eu.int
Table 1
Implementation of the budget for the financial year 2004
(million euro) |
||||||||||||||||
Revenue |
Expenditure |
|||||||||||||||
Origin of revenue |
Revenue entered in the final budget for the financial year |
Revenue collected |
Expenditure allocation |
Appropriations in the final budget |
Appropriations carried over from the previous financial year |
Appropriations available (2004 budget and financial year 2003) |
||||||||||
entered |
committed |
paid |
carried over |
cancelled |
outstanding commitments |
paid |
cancelled |
appro-priations |
committed |
paid |
carried over |
cancelled |
||||
Community subsidies (1) |
29 073 |
29 022 |
Title I Staff |
36 064 |
34 151 |
33 509 |
642 |
1 913 |
534 |
424 |
110 |
36 598 |
34 685 |
33 933 |
642 |
2 023 |
Own revenue |
67 000 |
67 350 |
Title II Administration |
23 994 |
23 878 |
12 943 |
10 935 |
116 |
7 265 |
6 749 |
516 |
31 259 |
31 143 |
19 692 |
10 935 |
632 |
Other revenue |
3 016 |
3 013 |
Title III Operating expenditure |
39 031 |
38 686 |
27 512 |
11 174 |
345 |
8 316 |
7 878 |
438 |
47 347 |
47 002 |
35 390 |
11 174 |
783 |
Total |
99 089 |
99 385 |
Total |
99 089 |
96 715 |
73 964 |
22 751 |
2 374 |
16 115 |
15 051 |
1 064 |
115 204 |
112 830 |
89 015 |
22 751 |
3 438 |
Table 2
Revenue and expenditure accounts for the financial years 2004 and 2003
(1000 euro) |
||
|
2004 |
2003 |
Revenue |
||
Fees relating to marketing authorisations |
68 412 |
58 657 |
Commission subsidy including subsidies received from the EEA |
20 529 |
19 786 |
Community subsidy for orphan medicines |
4 026 |
2 814 |
Contributions for Community programmes |
0 |
1 208 |
Administrative revenue |
1 973 |
1 703 |
Sundry revenue |
1 473 |
1 788 |
Total (a) |
96 413 |
85 956 |
Expenditure (2) |
||
Staff expenditure |
34 333 |
29 663 |
Administrative expenditure |
11 224 |
10 835 |
Operating expenditure |
38 573 |
32 838 |
Depreciation |
3 650 |
2 364 |
Other expenditure |
280 |
0 |
Total (b) |
88 060 |
75 700 |
Surplus from operating activities (c = a - b) |
8 353 |
10 256 |
Financial operations (e) |
1 160 |
676 |
Economic result (f = c + e) |
9 513 |
10 932 |
Table 3
Balance sheet as at 31 December 2004 and 31 December 2003
(1000 euro) |
|||||
Assets |
2004 |
2003 |
Liabilities |
2004 |
2003 |
Intangible assets |
5 109 |
3 401 |
Own capital |
|
|
Fixed assets |
|
|
|
|
|
Plant, machinery and tools |
2 480 |
1 635 |
Economic outturn |
9 513 |
10 932 |
Furniture and vehicle fleet |
1 375 |
1 011 |
Outturn carried over from previous financial years |
13 767 |
6 872 |
Computer equipment |
3 151 |
2 548 |
Subtotal |
23 280 |
17 804 |
Subtotal |
7 006 |
5 194 |
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Salaries |
320 |
0 |
Current assets |
|
|
Amounts owed to Community institutions and bodies |
4 910 |
479 |
VAT paid and to be recovered |
1 888 |
1 105 |
Payment appropriations to be carried over |
13 151 |
11 936 |
Amounts receivable from Community institutions and bodies |
148 |
107 |
Sundry accounts payable |
106 |
127 |
Sundry accounts receivable |
1 795 |
1 034 |
Advances from customers |
11 250 |
8 845 |
Sundry receivables |
2 061 |
64 |
Subtotal |
29 737 |
21 387 |
Subtotal |
5 892 |
2 310 |
|
|
|
Available assets |
35 010 |
28 286 |
|
|
|
Total |
53 017 |
39 191 |
Total |
53 017 |
39 191 |
(1) Includes subsidies received from the European Economic Area.
(2) The portion of the appropriations carried over which is to be regarded as expenditure for the financial year has been evaluated on an overall basis rather than on the basis of examining individual transactions.